ArticleJournal of oral and maxillofacial pathology : JOMFP
A comparative analysis of the burden of lip and oral cavity cancers in the Indian subcontinent.
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Oral Cancer Screening: A Biosocial Analysis of Global Barriers-A Narrative Review of Who Screens, Who Gets Screened, and Why.Cancers · 2026Review
- Article
- Global burden of lip and oral cavity cancer across adults aged ≥45 years from 1990 to 2021 and projections to 2050.Tobacco induced diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lip and oral cavity cancers are among the top 10 cancer causes and mortality globally. Some countries in the Indian subcontinent bear a disproportionately higher burden of lip and oral cavity cancers. Detailed analysis of lip and oral cavity cancers in the Indian subcontinent using all available data is important for effective policy planning. This paper aims to summarise the total burden of lip and oral cavity cancer and compare it across countries within the Indian subcontinent. Materials and Methods: Data from the Global Cancer Observatory (GCO) and Global Burden of Disease (GBD) Study were extracted to analyse cancer incidence, prevalence, mortality and cancer risk before reaching 74 years. Furthermore, summary estimates of years of life lost (YLL), years lived with disability (YLDs) and disability-adjusted life years (DALYs) attributable to lip and oral cavity cancers were extracted from the GBD database. The data of individual countries within the Indian subcontinent were used for comparison. Results: The estimated number of deaths from lip and oral cavity cancers for 2019 was 90732 in the Indian subcontinent. The Indian subcontinent accounted for 45.3% of the deaths attributable to lip and oral cavity cancers. The incidence of lip and oral cavity cancers in the Indian subcontinent ranged from 3.18 per 100,000 population in Maldives to 12.76 per 100,000 population in Pakistan. The incidence rate of lip and oral cavity cancer in India was 7.54 per 100,000 population. However, due to the population size, India accounted for 104837 incident cases of lip and oral cavity cancers annually. The estimated number of prevalent and incident cases of lip and oral cavity cancers from the Indian subcontinent in 2019 was 0.46 million (30% of overall cases globally) and 0.15 million (39% of incident cases globally), respectively. The Indian subcontinent also accounted for 50% of the DALYs attributable to lip and oral cavity cancers worldwide. Discussion and Conclusion: The Indian subcontinent accounts for disproportionately higher cases and deaths due to lip and oral cavity cancers than other regions. It calls for urgent policy action to prevent the disease spread, early diagnosis and optimal management of lip and oral cavity cancers in the Indian subcontinent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.